76 related articles for article (PubMed ID: 5090682)
1. Comparative study on two further attenuated live measles virus vaccines, "CAM" and "Moraten".
Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S
Biken J; 1971 Mar; 14(1):77-9. PubMed ID: 5090682
[No Abstract] [Full Text] [Related]
2. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
[No Abstract] [Full Text] [Related]
3. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
[No Abstract] [Full Text] [Related]
4. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
5. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
[No Abstract] [Full Text] [Related]
6. Mass immunization of children in Iran with live attenuated Sugiyama measles virus adapted to calf kidney cell cultures.
Mirchamsy H; Shafyi A; Bahrami S; Nazari P; Mirzadeh M; Bassali Y
Jpn J Exp Med; 1971 Feb; 41(1):39-48. PubMed ID: 5313449
[No Abstract] [Full Text] [Related]
7. Development of extremely attenuated live measles virus vaccine (CAM-EX).
Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
[No Abstract] [Full Text] [Related]
8. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
Ueda S; Okuno Y; Sakamoto Y
Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
[No Abstract] [Full Text] [Related]
9. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
[No Abstract] [Full Text] [Related]
10. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
[No Abstract] [Full Text] [Related]
11. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
[No Abstract] [Full Text] [Related]
12. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
Tanaka H
Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
[No Abstract] [Full Text] [Related]
13. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
[No Abstract] [Full Text] [Related]
14. [Vaccination against measles].
Cocchi P; Corti R
Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
[TBL] [Abstract][Full Text] [Related]
15. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
Sekiguchi H; Numazaki Y; Ikeda M; Yano N
Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
[No Abstract] [Full Text] [Related]
16. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of four live measles vaccines in Israel.
Swartz T; Klingberg W; Nishmi M; Goldblum N; Gerichter C; Yofe Y; Cockburn WC
Bull World Health Organ; 1968; 39(2):285-92. PubMed ID: 5303410
[TBL] [Abstract][Full Text] [Related]
18. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC].
Adam E; Fosenbauerová E; Domorázková E; Kratochvílová M; Kubátová E; Mares I; Drevo M; Svandová E
Cesk Pediatr; 1968 Jul; 23(7):581-93. PubMed ID: 5681931
[No Abstract] [Full Text] [Related]
19. [On vaccination against measles with live and attenuated virus (Schwarz strain)].
Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G
Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383
[No Abstract] [Full Text] [Related]
20. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
Polna I; Naruszewicz-Lesiuk D; Pilecka T
Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
[No Abstract] [Full Text] [Related]
[Next] [New Search]
